JUL 26, 2018 10:30 PM PDT

Cannabinoids for Dementia

WRITTEN BY: Mauri Brueggeman

One area of interest in the last year, as medical cannabis moves into the mainstream, is the use of cannabinoids for the treatment of dementia.  To be clear, many of the scientists or providers looking to cannabis or cannabinoid products are really looking at treating the symptoms associated with dementia, rather than the cause of dementia itself.  According to the literature, around half of patients with dementia experience behavioral and psychological symptoms (BPSD) which are distressing for everyone involved including the patient, caregivers, and family.  While it is widely accepted to use anti-psychotics for these patients, many patients do not show significant improvement and suffer grave side effects as a result of that group of pharmaceuticals used.

There are many scientists itching to explore the use of cannabinoids for the treatment of dementia because of their connection to our own endocannabinoid system (ECS), which maintains many physiological balances within our bodies.  There have been multiple neurological benefits connected to and documented as being a result of cannabinoid presence in the body.  One of the critical roles of the ECS is regulation of message transmission via our cellular synapses.  The ECS has multiple components: already somewhat understood endocannabinoids including 2-arachidonoyl glycerol (2-AG) and anandamide, cannabinoid receptors (CB1 and CB2), and enzymes involved in the regulation and metabolism of endocannabinoids.

Phytocannabinoids, like tetrahydrocannabinol (THC) and cannabidiol (CBD), affect the ECS through use or agonistic action on the cannabinoid receptors located in the body.  It has been suggested that some of these ECS components, CB2 for example, have specific neuroprotection features and that these neuroprotective effects counteract the neurodegenerative process involved in many forms of dementia.  Researchers have even documented reduction in CB1 levels within the nervous system of patients with dementia.  One group of researchers found changes in expression and distribution of CB1 in Alzheimer’s patients.  In fact, THC decreases the amyloid beta-peptide aggregates characteristically found in Alzheimer’s patients.  In these data sets, the research points to cannabinoids having a direct effect on the pathogenesis of disease. 

In other types of dementia where pathogenesis is less well understood, cannabinoids have been suggested to provide relief from the common BPSD felt by patients and those close to them including depression, anxiety, agitation, aggression, wandering, issues sleeping, and others. 

Sources: Neurodegenerative Disease Management, Cochrane Database of Systematic Reviews,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
MAY 12, 2020
Cannabis Sciences
Cannabis Use Not Linked to Low IQ
MAY 12, 2020
Cannabis Use Not Linked to Low IQ
While 12% of adults in the US claim to have smoked cannabis, the same figure stands at 22% for those aged between 18 and ...
JUL 01, 2020
Health & Medicine
Could THC Help Advanced Alzheimer's Symptoms?
JUL 01, 2020
Could THC Help Advanced Alzheimer's Symptoms?
More than 5 million Americans are living with Alzheimer's disease (AD) according to the Alzheimer's Organization. When t ...
JUL 29, 2020
Health & Medicine
The Carrier Oil Matters When it Comes to CBD Products
JUL 29, 2020
The Carrier Oil Matters When it Comes to CBD Products
The type of oil that is used to extract and carry the medicinally active ingredients (cannabinoids and terpenes) in cann ...
AUG 10, 2020
Cannabis Sciences
Cannabis Use During Pregnancy Linked to Autism
AUG 10, 2020
Cannabis Use During Pregnancy Linked to Autism
Researchers from The Ottawa Hospital in Ontario, Canada, have found that children born to mothers who used cannabis whil ...
AUG 24, 2020
Cannabis Sciences
Vets Warn Against Using CBD for Pets
AUG 24, 2020
Vets Warn Against Using CBD for Pets
As cannabis products have grown in popularity, the stigma around them is falling, while knowledge is increasing. CBD, th ...
SEP 03, 2020
Cannabis Sciences
Hemp Extract Protects Bees from Poisonous Pesticides
SEP 03, 2020
Hemp Extract Protects Bees from Poisonous Pesticides
Researchers from Curie-Skłodowska University in Poland have found that an extract from hemp may help bees to survive poi ...
Loading Comments...